BioNTech SE (BNTX) Revenue (2018 - 2025)
BioNTech SE (BNTX) posted Revenue of $1.1 billion for Q4 2025, down 40.52% sequentially from $1.8 billion in Q3 2025, and down 99.97% YoY from $3526.4 billion in Q4 2024.
BioNTech SE (BNTX) Revenue (2018 - 2025) Analysis & Trends
BioNTech SE has reported Revenue for 8 years, with the latest figure at $1.1 billion in Q4 2025.
- Quarterly Revenue fell 99.97% year-over-year to $1.1 billion in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $3.3 billion (down 99.91% YoY) and the FY2025 annual result came in at $3.2 billion, up 10.29% from the prior year.
- Revenue declined to $1.1 billion in Q4 2025 per BNTX's latest filing, from $1.8 billion in the prior quarter.
- Over five years, Revenue peaked at $3526.4 billion in Q4 2024 and troughed at $138.6 million in Q2 2024.
- A 5-year average of $178.8 billion and a median of $1.7 billion in 2023 frame the typical range for Revenue.
- The sharpest annual moves came in 2021 and 2024: Revenue tumbled 100.0% in 2021, then soared 221500.66% in 2024.
- Over 5 years, Revenue stood at $6.3 billion in 2021, then tumbled by 31.03% to $4.4 billion in 2022, then slumped by 63.54% to $1.6 billion in 2023, then jumped by 221500.66% to $3526.4 billion in 2024, then slumped by 99.97% to $1.1 billion in 2025.
- According to Business Quant data, Revenue over the past three periods registered $1.1 billion, $1.8 billion, and $295.2 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 3.33 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 4.29 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.56 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.71 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 3,001.92 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 674.14 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.29 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 425.49 Mn |
| 10 | BioNTech SE | 23.54 Bn | 5.15 Bn | 668.28 Mn | 1.06 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.06 Bn |
| Sep 30, 2025 | 1.78 Bn |
| Jun 30, 2025 | 295.22 Mn |
| Mar 31, 2025 | 192.28 Mn |
| Dec 31, 2024 | 1.27 Bn |
| Sep 30, 2024 | 1.37 Bn |
| Jun 30, 2024 | 138.60 Mn |
| Mar 31, 2024 | 203.80 Mn |
| Dec 31, 2023 | 1.59 Bn |
| Sep 30, 2023 | 974.62 Mn |
| Jun 30, 2023 | 182.61 Mn |
| Mar 31, 2023 | 1.37 Bn |
| Dec 31, 2022 | 4.36 Bn |
| Sep 30, 2022 | 3.49 Bn |
| Jun 30, 2022 | 3.41 Bn |
| Mar 31, 2022 | 7.15 Bn |
| Dec 31, 2021 | 6.33 Bn |
| Sep 30, 2021 | 7.18 Bn |
| Jun 30, 2021 | 6.39 Bn |
| Mar 31, 2021 | 2.47 Bn |